Skip to content

Application of sciatic nerve block using lidocaine preoperatively and lipid bupivacaine postoperatively in rapid rehabilitation of foot and ankle surgery

Application of sciatic nerve block using lidocaine preoperatively and lipid bupivacaine postoperatively in rapid rehabilitation of foot and ankle surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096269
Enrollment
Unknown
Registered
2025-01-21
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

A group:Lidocaine for sciatic nerve block preoperatively and liposomal bupivacaine for sciatic nerve block postoperatively
B group:Ropivacaine for sciatic nerve block preoperatively

Sponsors

Shanghai Jiao Tong University Affiliated Sixth people’s hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-70 years old; (2) Patients undergoing foot and ankle surgery (such as open reduction and internal fixation for fractures, bunion correction, and other procedures lasting less than 2 hours) (3) American Society of Anesthesiologists (ASA) grade I to II. (4) Voluntary and signed informed consent. (5) Subjects with a working phone.

Exclusion criteria

Exclusion criteria: (1) History of allergy to the study drugs used in this study (2) Body mass index (BMI) >40 kg/m2; (3) Combined with neuromuscular diseases (such as muscle weakness, Parkinson's disease, etc.); (4) Suffered from mental illness (such as Alzheimer's disease, epilepsy, etc.) ; (5) Preoperative limb sensory impairment ; (6) Local skin infection or coagulation disorder; (7) Suffering from severe systemic diseases or liver and kidney dysfunction; (8) Patients who refuse to participate in the study.

Design outcomes

Primary

MeasureTime frame
Postoperative strength of toes or ankle at 3 hours;Postoperative visual analogue scale(VAS) at 24 hours;

Secondary

MeasureTime frame
Consumption of opioids (e.g., sufentanil) ;Satisfaction and quality of recovery within 24 hours after surgery(QoR-15);Incidence of postoperative adverse events (such as nausea and vomiting, urinary retention, adverse reactions to local anesthetics, etc.).;Analgesic rescue;Postoperative strength of toes or ankle at 0,6,12,24 hours;The proportion of participants in rehabilitation treatment within 24 hours and 48 hours after surgery;Postoperative visual analogue scale(VAS) at 0,3,6,12, 72 hours;Time to onset of preoperative nerve block;The onset, resolution and duration of sensory and motor blockade;Proportion of patients who are pain-free and without salvage medication at each time;The percentage patients who are not using opioids after surgery;

Countries

China

Contacts

Public ContactAizhong Wang

Shanghai Jiao Tong University Affiliated Sixth people’s hospital

w19680420@sohu.com+86 189 3017 7431

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026